查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球左心室輔助裝置 (LVAD) 市場 - 2023-2030 年
市場調查報告書
商品編碼
1316287

全球左心室輔助裝置 (LVAD) 市場 - 2023-2030 年

Global Left Ventricular Assist Device (LVAD) Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

2022 年，全球左心室輔助裝置(LVAD) 市場規模達到14 億美元，預計到2030 年將實現利潤豐厚的成長，達到23 億美元。在預測期內（2023-2030 年），全球左心室輔助裝置(LVAD) 市場的複合年成長率預計將達到7.2%。

左心室輔助裝置（VAD）是一種機械循環支持策略，通過將血液從心臟腔室泵送至全身，在心衰患者中廣泛應用。預計在預測期內，心力衰竭人數的增加、新產品的推出、技術的進步和市場的不斷發展等因素將推動全球左心室輔助裝置（LVAD）市場的成長。

市場動態

心衰病例的增加推動了左心室輔助裝置（LVAD）市場的成長。

預計在預測期內，心力衰竭病例的增加將推動全球左心室輔助裝置市場的成長。心力衰竭極為典型。儘管在治療多種心臟疾病方面取得了進展，但心力衰竭仍是全球日益關注的問題。例如，根據美國心力衰竭協會（Heart Failure Society of America）的評估，目前有近650 萬20 歲以上的美國人患有心力衰竭。一項重要的調查評估顯示，每年有超過96 萬名新的心力衰竭患者。心力衰竭不僅是一個影響相當多的人的重大問題，而且心力衰竭甚至是一個突出的殺手。在美國，心力衰竭直接導致的死亡人數約佔所有心臟病死亡人數的8.5%。據估計，心力衰竭導致的死亡人數約佔心血管疾病死亡總人數的36%。

研究活動的增加有望為全球左心室輔助裝置（LVAD）市場帶來成長機會。

越來越多的研究活動預計將推動全球左心室輔助裝置市場的發展。例如，在確保獲得FDA 授權的首要行動中，總部位於以色列的設備製造商Magenta Medical 正在對其用於高風險經皮冠狀動脈介入治療（HR-PCI）的Elevate 經皮左心室輔助裝置（pLVAD）啟動一項不成熟的可行性調查。

預計在預測期內，高昂的左心室輔助裝置植入費用將阻礙全球左心室輔助裝置（LVAD）市場的發展。

據估計，在預測期內，植入左心室輔助裝置的高昂費用將阻礙全球左心室輔助裝置市場的發展。例如，根據美國國立衛生研究院（NIH）的數據，植入LVAD 的平均費用為175,420 美元。然而，LVAD 證明心力衰竭患者的生活品質得到了改善，但由於頻繁的再入院和昂貴的後續護理，終生成本大幅增加。

COVID-19 影響分析

COVID-19 在全球許多國家的流行和封鎖影響了各行各業公司的財務健康。因此，在COVID-19 公共衛生緊急事件期間，美國食品和藥物管理局(FDA) 發布了指導方針，其中包括幫助申辦者和研究人員的一般注意事項，以確保試驗參與者的安全、遵守良好臨床實踐(GCP)，並最大限度地降低試驗完整性的風險。

俄烏戰爭影響分析

俄羅斯與烏克蘭的衝突被認為對全球左心室輔助裝置（LVAD）市場的影響不大，因為該地區的心力衰竭發病率較低，而且缺乏主要的市場參與者。儘管烏克蘭軍隊繼續抵禦俄羅斯軍隊的入侵，但由於死亡人數不斷增加，醫療援助有限，烏克蘭的診所也不得不這樣做。所有類型的藥品都出現短缺。同樣，原料進出口的重要性預計將在預測期內對全球左心室輔助裝置（LVAD）市場的成長產生輕微影響。

目 錄

第1 章：研究方法與範圍

  • 研究方法
  • 報告的研究目標和範圍

第2章：定義和概述

第3 章：執行摘要

  • 按類型摘錄
  • 按泵類型分類
  • 按最終用戶分類
  • 按區域分類

第四章：動態

  • 影響因素
    • 驅動因素
      • 越來越多的產品獲得批准。
      • 心力衰竭發病率成長。
    • 制約因素
      • 成本高。
    • 機會
      • 研究活動日益增多
    • 影響分析

第5 章：行業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情況
    • COVID-19 期間的情景
    • COVID-19 後的情況
  • COVID-19 期間的定價動態
  • 供需關係
  • 大流行期間與市場相關的政府計劃
  • 製造商的戰略計劃
  • 結論

第7 章：按類型分類

  • 經皮LVAD
  • 植入式LVAD
  • 其他類型

第8 章：按泵類型

  • 第一代設備
  • 第二代設備
  • 第三代設備
  • 其他

第九章：按應用分類

  • 橋接康復（BTR）療法
  • 橋接移植療法（BTT）
  • 目的地療法
  • 橋接治療（BTC）
  • 其他療法

第10章：按最終用戶分類

  • 醫院
  • 心臟病中心
  • 其他

第11 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
      • 亞太其他地區
  • 中東和非洲
    • 特定地區的主要動態

第12 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 合併與收購分析

第13 章：公司簡介

  • CorWave.
    • 公司概況
    • 類型組合和描述
    • 財務概況
    • 主要發展
  • Apaxis Inc.
  • Sunshine Heart.
  • HeartWare International (Medtronic)
  • Sun Medical Technology Research
  • Abiomed
  • Terumo Corporation
  • Evaheart
  • Jarvik Heart
  • Thoratec (Abbott)

第14 章：附錄

簡介目錄
Product Code: MD2890

Market Overview

The global left ventricular assist device (LVAD) market reached US$ 1.4 billion in 2022 and is expected to witness lucrative growth by reaching up to US$ 2.3 billion by 2030. The global left ventricular assist device (LVAD) market is expected to exhibit a CAGR of 7.2% during the forecast period (2023-2030).

Left Ventricular Assist Devices (VAD) are mechanical circulatory support strategies planted in heart failure individuals with intense manifestation and operation by pumping blood from the chambers of the heart to the entire body. The increase in the number of heart failures, rising type launches, advancements, and increasing market developments are among the factors expected to boost the global left ventricular assist device (LVAD) market growth in the forecast period.

Market Dynamics

Increasing Cases Of Heart Failure Drive The Growth Of The Left Ventricular Assist Device (LVAD) Market.

The increasing cases of heart failure are expected to boost the global left ventricle assist device market growth in the forecast period. Heart failure is extremely typical. Although improvement is created in the treatment of multiple states of heart conditions, heart failure is a growing concern globally. For instnace, according to the Heart Failure Society of America, the current assessments are that nearly 6.5 million Americans over the age of 20 suffer heart failure. One significant investigation assessment indicates that there are over 960,000 fresh heart failure patients yearly. Not only is heart failure a significant issue impacting a considerable number of individuals, but heart failure is even a prominent killer. Heart failure directly accounts for approximately 8.5% of all heart condition deaths in the United States. And, to some assessments, heart failure contributes to about 36% of all cardiovascular disease deaths.

The Increase in Research Activities is Expected To Present The Global Left Ventricular Assist Device (LVAD) Market With Growth Opportunities.

Increasing research initiatives are estimated to boost the global For instance, in the foremost action in ensuring FDA authorization, Israel-based device maker Magenta Medical is initiating a premature feasibility investigation with its Elevate percutaneous Left Ventricular Assist Device (pLVAD) for high-risk percutaneous coronary intervention (HR-PCI).

The High Cost of LVAD Implantation is Estimated To Hamper The Global Left Ventricular Assist Device (LVAD) Market During The Forecast Period.

The high cost of LVAD implantation is estimated to hamper the global left ventricular assist device market growth in the forecast period. For instance, according to the NIH, the mean cost of LVAD implantation was USD 175,420. However, LVADs proven heart failure patients improved quality of life but substantially increased lifetime costs because of frequent readmissions and costly follow-up care.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is thought to hold a moderate influence on the global left ventricular assist device (LVAD) market, as there is a low incidence of heart failure and a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all types of medications. Again, the significance of the import and export of raw materials are expected to slightly impact the global Left Ventricular Assist Device (LVAD) market growth in the forecast period.

Segment Analysis

The global left ventricular assist device (LVAD) market is segmented based on type, pump type, application, end-user, and region.

The Implantable LVAD Type is Estimated to Dominate the Global Left Ventricular Assist Device (LVAD) Market.

Owing to the increase in the procedures of implantable LVAD, implantable LVAD is estimated to hold around 23.9% of the global market share by 2030. For instnace, in July 2022, a team from Emory's Heart and Vascular Center conducted its 500th continuous flow, durable left ventricular assist device (LVAD) implantation, additionally establishing Emory Healthcare's position as a national leader in the life-saving procedure.

Geographical Analysis

Europe is Estimated to Hold 27.1% of the Market Share Owing to the Key Player's Efforts in this Region.

Owing to the key player's efforts in the Europe region, the region is estimated to hold around 27.1% of the global market share. For instance, UK-based Calon Cardio-Technology Ltd. seeks to obtain the CE Mark for its MiniVAD in earlier 2024, by which period a US FDA Early Feasibility Study is expected to have been concluded. The corporation pursues to boost investments of almost USD 47 million (£34 million) to USD 60 million (£43 million) to finance its clinical investigations of the MiniVAD in the US and Europe from 2020 to 2023.

Competitive Landscape

The major global players in the Left Ventricular Assist Device (LVAD) market include: CorWave, Apaxis Inc., Sunshine Heart, HeartWare International (Medtronic), Sun Medical Technology Research, Abiomed, Terumo Corporation, Evaheart, Jarvik Heart, and Thoratec (Abbott), among others.

Why Purchase the Report?

  • To visualize the global left ventricular assist device (LVAD) market segmentation based on type, pump type, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of left ventricular assist device (LVAD) market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Type mapping available in Excel consisting of key Types of all the major players.

The global left ventricular assist device (LVAD) market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Pump Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Product Approvals.
      • 4.1.1.2. Growing Incidences of Heart Failure.
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost.
    • 4.1.3. Opportunity
      • 4.1.3.1. Increasing Research Activities
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Transcutaneous LVAD *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Implantable LVAD
  • 7.4. Others

8. By Pump Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pump Type
    • 8.1.2. Market Attractiveness Index, By Pump Type
  • 8.2. First-Generation Devices*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Second-Generation Devices
  • 8.4. Third-Generation Devices
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Bridge-to-Recovery (BTR) Therapy *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Bridge-to-Transplant (BTT) Therapy
  • 9.4. Destination Therapy
  • 9.5. Bridge-to-Candidacy (BTC) Therapy
  • 9.6. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Cardiology Centers
  • 10.4. Other

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pump Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pump Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pump Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pump Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan

Australia

      • 11.5.7.4. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pump Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. CorWave.*
    • 13.1.1. Company Overview
    • 13.1.2. Type Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Apaxis Inc.
  • 13.3. Sunshine Heart.
  • 13.4. HeartWare International (Medtronic)
  • 13.5. Sun Medical Technology Research
  • 13.6. Abiomed
  • 13.7. Terumo Corporation
  • 13.8. Evaheart
  • 13.9. Jarvik Heart
  • 13.10. Thoratec (Abbott)

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us